Publication:
Gene Therapy Using a Self-Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott-Aldrich Syndrome

dc.contributor.authorsChu, Julia I.; Henderson, Lauren A.; Armant, Myriam; Male, Frances; Dansereau, Colleen H.; MacKinnon, Brenda; Burke, Christopher J.; Cavanaugh, Matthew E.; London, Wendy B.; Barlan, Isil B.; Ozen, Ahmet; Baris, Safa; Karakoc-Aydiner, Elif; Kiykirn, Ayca; Hanson, Imelda Celine; Despotovic, Jenny M.; Saitoh, Akihiko; Takachi, Takayuki; Imai, Kohsuke; King, Alejandra; Arredondo, Silvia; Ritz, Jerome; Bushman, Frederic D.; Galy, Anne; Notarangelo, Luigi Daniele; Williams, David A.; Pai, Sung-Yun
dc.date.accessioned2022-03-12T16:15:52Z
dc.date.accessioned2026-01-11T10:32:33Z
dc.date.available2022-03-12T16:15:52Z
dc.date.issued2015
dc.identifier.doi10.1182/blood.V126.23.260.260
dc.identifier.eissn1528-0020
dc.identifier.issn0006-4971
dc.identifier.urihttps://hdl.handle.net/11424/225666
dc.identifier.wosWOS:000368019001012
dc.language.isoeng
dc.publisherAMER SOC HEMATOLOGY
dc.relation.ispartofBLOOD
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleGene Therapy Using a Self-Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott-Aldrich Syndrome
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.issue23
oaire.citation.titleBLOOD
oaire.citation.volume126

Files